Course: Buprenorphine Treatment Divide by Race/Ethnicity and Payment
CME Credits: 1.00
Released: 2019-05-08
Opioid mortality rates continue to increase throughout the United States; however, growth in buprenorphine hydrochloride treatment for opioid use disorder (OUD) might be limited to communities with higher income and low percentages of racial/ethnic minorities. Buprenorphine, a partial opioid agonist, is 1 of 3 evidence-based medications for treating OUD and can legally be prescribed in office-based settings.
Educational Objective
To understand the relationship between race, ethnicity and economic factors and buprenorphine treatment.
View Full Course